MCID: EPD003
MIFTS: 47

Epidermolysis Bullosa Simplex malady

Categories: Genetic diseases, Rare diseases, Skin diseases

Aliases & Classifications for Epidermolysis Bullosa Simplex

About this section

Aliases & Descriptions for Epidermolysis Bullosa Simplex:

Name: Epidermolysis Bullosa Simplex 10 21 45 22 23 47 12 36 24 65
Ebs 22 23
 
Epidermolysis Bullosa Intraepidermic 45

Classifications:



External Ids:

Disease Ontology10 DOID:4644
ICD1027 Q81.0
SNOMED-CT59 205585003, 67144006
MeSH36 D016110
NCIt42 C84692
UMLS65 C0079298

Summaries for Epidermolysis Bullosa Simplex

About this section
NIH Rare Diseases:45 Epidermolysis bullosa simplex (ebs) is one of the major forms of epidermolysis bullosa, a group of genetic conditions that cause the skin to be very fragile and to blister easily. ebs is classified into two groups of subtypes by the layer of skin at which the peeling originates. the basal subtypes cause skin peeling at the lower layers of the epidermis. the most common basal subtypes include ebs localized, dowling meara ebs, generalized other ebs and ebs with muscular dystrophy. more rarely seen basal subtypes include ebs with mottled pigmentation, ebs with pyloic atreseia, ebs ogna, and ebs circinate migratory.the suprabasal subtypes cause skin peeling at the upper layers of the epidermis and include the rare forms known as lethal acantolythic eb, plakophilin deficiency, and ebs superficialis (ebss). symptoms of ebs range from mild in the weber-cockayne type to severe with blistering that is present at birth or after. milder phenotypes of ebs have blistering confined to the limbs, whereas in the most severe dowling meara type, blisters may also form in the mouth. all of the types are typically caused by mutations in the krt5 and krt14 genes. they are usually inherited in an autosomal dominant pattern, but autosomal recessive inheritance has occurred in rare cases. treatment plans differ depending on severity but typically focus on preventing formation of blisters, caring for blistered skin, and treating infection. last updated: 7/22/2011

MalaCards based summary: Epidermolysis Bullosa Simplex, also known as ebs, is related to epidermolysis bullosa simplex, weber-cockayne type and epidermolysis bullosa simplex-mp, and has symptoms including abnormal blistering of the skin, palmoplantar keratoderma and abnormality of skin pigmentation. An important gene associated with Epidermolysis Bullosa Simplex is KRT5 (Keratin 5), and among its related pathways are a6b1 and a6b4 Integrin signaling and Glucocorticoid receptor regulatory network. Affiliated tissues include skin, prostate and bone, and related mouse phenotype integument.

Genetics Home Reference:23 Epidermolysis bullosa simplex is one of a group of genetic conditions called epidermolysis bullosa that cause the skin to be very fragile and to blister easily. Blisters and areas of skin loss (erosions) occur in response to minor injury or friction, such as rubbing or scratching. Epidermolysis bullosa simplex is one of the major forms of epidermolysis bullosa. The signs and symptoms of this condition vary widely among affected individuals. Blistering primarily affects the hands and feet in mild cases, and the blisters usually heal without leaving scars. Severe cases of this condition involve widespread blistering that can lead to infections, dehydration, and other medical problems. Severe cases may be life-threatening in infancy.

Wikipedia:68 Epidermolysis bullosa simplex (EBS) is a disorder resulting from mutations in the genes encoding keratin... more...

GeneReviews summary for NBK1369

Related Diseases for Epidermolysis Bullosa Simplex

About this section

Diseases in the Epidermolysis Bullosa Simplex family:

Epidermolysis Bullosa Simplex, Recessive 1 Krt14-Related Epidermolysis Bullosa Simplex

Diseases related to Epidermolysis Bullosa Simplex via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 309)
idRelated DiseaseScoreTop Affiliating Genes
1epidermolysis bullosa simplex, weber-cockayne type35.3KRT14, KRT5
2epidermolysis bullosa simplex-mp35.2KRT14, KRT5
3epidermolysis bullosa simplex, dowling-meara type34.4KRT1, KRT10, KRT14, PLEC
4lymphoepithelioma-like carcinoma30.9KRT14, KRT5
5strabismus30.8KRT14, KRT5
6epidermolysis bullosa simplex, koebner type13.1
7epidermolysis bullosa simplex, ogna type13.0
8epidermolysis bullosa simplex with muscular dystrophy13.0
9epidermolysis bullosa simplex with pyloric atresia13.0
10epidermolysis bullosa simplex, sutosomal recessive 212.9
11epidermolysis bullosa simplex, recessive 112.8
12epidermolysis bullosa simplex with nail dystrophy12.8
13epidermolysis bullosa simplex with anodontia/hypodontia12.8
14epidermolysis bullosa simplex due to bp230 deficiency12.8
15epidermolysis bullosa simplex superficialis12.8
16epidermolysis bullosa simplex due to exophilin 5 deficiency12.7
17krt14-related epidermolysis bullosa simplex12.7
18epidermolysis bullosa simplex, other generalized12.6
19epidermylysis bullosa simplex-mcr12.5
20ectodermal dysplasia/skin fragility syndrome12.1
21epidermolysa bullosa simplex with muscular dystrophy11.6
22epidermolysis bullosa, late-onset localized junctional, with mental retardation11.6
23epidermolysis bullosa11.1
24epidermolysis bullosa, lethal acantholytic10.7
25epidermolysis bullosa dystrophica, ad10.6
26breast cancer10.5
27pachyonychia congenita 310.5KRT14, KRT5
28leukemia10.5
29dowling-degos disease 110.5KRT14, KRT5
30bile duct mucoepidermoid carcinoma10.5KRT14, KRT5
31female breast upper-inner quadrant cancer10.4KRT14, KRT5
32breast ductal carcinoma10.4KRT14, KRT5
33arthritis10.4
34lymphoma10.4
35endotheliitis10.4
36sebaceous adenocarcinoma10.4KRT14, KRT5
37ovarian clear cell adenocarcinoma10.4KRT14, KRT5
38lichen planus pigmentosus10.4COL17A1, DST
39integumentary system cancer10.4KRT14, KRT5
40pemphigus and fogo selvagem10.4COL17A1, DST
41muscular dystrophy, limb-girdle, type 2q10.4ITGB4, PLEC
42asthma10.4
43cervicitis10.4
44adenoma10.4
45epimerase deficiency galactosemia10.4ITGB4, PLEC
46liver leiomyoma10.3COL17A1, DST
47chorea gravidarum10.3COL17A1, DST
48localized lipodystrophy10.3COL17A1, ITGB4
49epidermolysis bullosa, junctional, non-herlitz type10.3COL17A1, ITGB4
50nodular basal cell carcinoma10.3KRT10, KRT14

Graphical network of the top 20 diseases related to Epidermolysis Bullosa Simplex:



Diseases related to epidermolysis bullosa simplex

Symptoms for Epidermolysis Bullosa Simplex

About this section

HPO human phenotypes related to Epidermolysis Bullosa Simplex:

(show all 9)
id Description Frequency HPO Source Accession
1 abnormal blistering of the skin hallmark (90%) HP:0008066
2 palmoplantar keratoderma typical (50%) HP:0000982
3 abnormality of skin pigmentation typical (50%) HP:0001000
4 anonychia typical (50%) HP:0001798
5 pyloric stenosis typical (50%) HP:0002021
6 skin ulcer typical (50%) HP:0200042
7 atypical scarring of skin occasional (7.5%) HP:0000987
8 abnormality of the fingernails occasional (7.5%) HP:0001231
9 neoplasm occasional (7.5%) HP:0002664

Drugs & Therapeutics for Epidermolysis Bullosa Simplex

About this section

Drugs for Epidermolysis Bullosa Simplex (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 19)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
ErythromycinapprovedPhase 392114-07-812560
Synonyms:
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
,10-dione
114-07-8
3''-O-demethylerythromycin
374700-25-1
45673_FLUKA
45674_FLUKA
79235-06-6
82343-12-2
A/T/S
AC-12744
AC1L1FIQ
AC1L1QK7
AC1L1ZUR
AC1O8PVA
AC1Q2UA1
AC1Q6O1S
AI3-50138
AR-1A4414
AR-1H0723
Abboticin
Abomacetin
Acneryne
Acnesol
Ak-Mycin
Ak-mycin
Akne Cordes Losung
Akne-Mycin
Akne-mycin
Akne-mycin (TN)
Aknederm Ery Gel
Aknemycin
Aknin
AustriaS
BB_NC-1332
BIDD:GT0017
BPBio1_000312
BSPBio_000282
BSPBio_002480
Benzamycin
Benzamycin Pak
Bristamycin
C-Solve-2
C01912
C37H67NO13
CCRIS 9078
CHEBI:42355
CHEMBL532
CID12560
CID3255
CID6713919
CID8233
D00140
DB00199
Del-Mycin
Derimer
Deripil
DivK1c_000294
DivK1c_000397
DivK1c_000702
Dotycin
Dumotrycin
E- mycin, Erycin, Robimysin
E-Base
E-Base (base)
E-Glades
E-Mycin
E-Mycin (base)
E-Solve 2
E.e.s
E.e.s.
E0751
E0774_SIAL
E5389_SIGMA
E6376_SIAL
E7904_SIGMA
EINECS 204-040-1
EM
EMU
ERY
ERYC
ERYC (base)
ERYTHROMYCIN STEARATE
ETS
Emgel
Emu-V
Emu-Ve
Emuvin
Emycin
Endoeritrin
Erecin
Erimycin-T
Erisone
Eritomicina
Eritrocina
Eritromicina
Eritromicina [INN-Spanish]
Ermycin
Eros
Ery
Ery-B
Ery-Diolan
Ery-Sol
Ery-Tab
Ery-Tab (base)
Ery-maxin
Ery-ped
Ery-tab
Eryacne
Eryacnen
Erybid
Eryc
Eryc (TN)
Eryc 125
Eryc Sprinkles
Eryc-125
Eryc-250
Erycen
Erycette
Erycin
Erycinum
Eryderm
Erydermer
Erygel
Erygel (TN)
Eryhexal
Erymax
Erymed
Erypar
Erysafe
Erytab
Erythra-Derm
Erythra-derm
Erythro
Erythro-Statin
Erythro-Teva
Erythrocin
Erythrocin Stearate
Erythroderm
Erythrogran
Erythroguent
Erythromast 36
Erythromid
 
Erythromycin
Erythromycin & VRC3375
Erythromycin (JP15/USP/INN)
Erythromycin A
Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279
Erythromycin B
Erythromycin Base
Erythromycin Base Base
Erythromycin Base Filmtab
Erythromycin C
Erythromycin Lactate
Erythromycin Ointment
Erythromycin Stearate
Erythromycin [INN:BAN:JAN]
Erythromycin base
Erythromycin estolate
Erythromycin ethylsuccinate
Erythromycin glucoheptonate
Erythromycin intravenous
Erythromycin lactobionate
Erythromycin oxime
Erythromycin sodium lauryl sulfate
Erythromycin, compd. with monododecyl sulfate, sodium salt
Erythromycine
Erythromycine [INN-French]
Erythromycinum
Erythromycinum [INN-Latin]
Erytop
Erytrociclin
Ethril 250
HMS1568O04
HMS1920M04
HMS2091D05
HMS500O16
HSDB 3074
I06-0245
IDI1_000294
IDI1_000397
IDI1_000702
Ilocaps
Ilosone
Ilosone (estolate)
Iloticina
Ilotycin
Ilotycin Gluceptate
Ilotycin T.S
Ilotycin T.S.
Inderm
Inderm Gel
IndermRetcin
KBio1_000294
KBio1_000397
KBio1_000702
KBio2_000555
KBio2_001139
KBio2_003123
KBio2_003707
KBio2_005691
KBio2_006275
KBioGR_001175
KBioSS_000555
KBioSS_001139
KST-1A8261
Kesso-Mycin
LMPK04000006
LS-187077
LS-64648
Latotryd
Lederpax
MLS001066618
Mephamycin
Mercina
MolPort-000-772-161
MolPort-002-507-378
MolPort-003-933-429
N-Methylerythromycin A
NCGC00179619-01
NCI-C55674
NINDS_000294
NINDS_000397
NINDS_000702
NSC 55929
NSC55929
Oftalmolosa Cusi Eritromicina
Oftamolets
PCE Dispertab (base)
Paediathrocin
Pantoderm
Pantodrin
Pantomicina
Pce
Pce (TN)
Pfizer-e
Pharyngocin
Prestwick0_000151
Prestwick1_000151
Prestwick2_000151
Prestwick3_000151
Prestwick_205
Primacine
Propiocine
Proterytrin
R-P Mycin
Retcin
Robimycin
Romycin
SBB057401
SMP1_000119
SMR000544946
SPBio_000778
SPBio_001226
SPBio_002221
SPECTRUM1500280
STK249736
Sans-acne
Sansac
Serp-AFD
Skid Gel E
Spectrum2_000759
Spectrum2_001263
Spectrum4_000538
Spectrum5_001596
Spectrum_000115
Spectrum_000659
Staticin
Staticin (TN)
Stiemicyn
Stiemycin
Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin
T-Stat
T-stat (TN)
Taimoxin-F
Theramycin Z
Tiloryth
Tiprocin
Torlamicina
UNII-63937KV33D
Udima Ery Gel
Wemid
Wyamycin S
adecane-2,10-dione (non-preferred name)
bmse000664
erythro
erythromycin
nchembio.285-comp13
2Erythromycin stearatePhase 392
3Anti-Bacterial AgentsPhase 39140
4Erythromycin EthylsuccinatePhase 392
5Gastrointestinal AgentsPhase 36401
6Anti-Infective AgentsPhase 317220
7Erythromycin EstolatePhase 392
8
AcetylcholineexperimentalPhase 268951-84-3187
Synonyms:
ACh
Acetyl choline ion
Acetylcholine Chloride
Acetylcholine cation
 
Acetylcholinium: acetyl-Choline
Choline acetate
Choline acetate (ester)
Miochol E
O-Acetylcholine
acetylcholine chloride
9Neurotransmitter AgentsPhase 214795
10OnabotulinumtoxinAPhase 2588
11Peripheral Nervous System AgentsPhase 218510
12Neuromuscular AgentsPhase 2922
13Pharmaceutical SolutionsPhase 27004
14AnestheticsPhase 27385
15AbobotulinumtoxinAPhase 2588
16Botulinum ToxinsPhase 2616
17Botulinum Toxins, Type APhase 2588
18Cholinergic AgentsPhase 23243
19IncobotulinumtoxinAPhase 2599

Interventional clinical trials:

idNameStatusNCT IDPhase
1Treatment of Dowling Maera Type of Epidermolysis Bullosa Simplex by Oral ErythromycinRecruitingNCT01340235Phase 3
2Study of Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis BullosaRecruitingNCT02384460Phase 3
3Study of Effectiveness and Safety of SD-101 in Subjects With Epidermolysis BullosaCompletedNCT02014376Phase 2
4Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia CongenitaRecruitingNCT00936533Phase 2
5Diacerin for the Treatment of Epidermolysis Bullosa SimplexNot yet recruitingNCT02470689Phase 2
6Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal SkinRecruitingNCT02592954Phase 1
7Study of Inflammatory Mechanisms in Epidermolysis Bullosa Simplex- Dowling MearaCompletedNCT01556308
8Open Label Extension Study to Evaluate the Safety of SD-101 Cream in Subjects With Epidermolysis BullosaActive, not recruitingNCT02090283
9Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis BullosaActive, not recruitingNCT02670330

Search NIH Clinical Center for Epidermolysis Bullosa Simplex


Cochrane evidence based reviews: epidermolysis bullosa simplex

Genetic Tests for Epidermolysis Bullosa Simplex

About this section

Genetic tests related to Epidermolysis Bullosa Simplex:

id Genetic test Affiliating Genes
1 Epidermolysis Bullosa Simplex22 KRT5, KRT14

Anatomical Context for Epidermolysis Bullosa Simplex

About this section

MalaCards organs/tissues related to Epidermolysis Bullosa Simplex:

33
Skin, Prostate, Bone, Brain, Breast, Liver, Smooth muscle

Animal Models for Epidermolysis Bullosa Simplex or affiliated genes

About this section

MGI Mouse Phenotypes related to Epidermolysis Bullosa Simplex:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00107718.8ITGB4, KRT1, KRT14, KRT17, KRT5, PLEC

Publications for Epidermolysis Bullosa Simplex

About this section

Articles related to Epidermolysis Bullosa Simplex:

(show top 50)    (show all 327)
idTitleAuthorsYear
1
Effects of Soothing Liver and Invigorating Spleen Recipes on the IKKI^-NF-I_B Signaling Pathway in Kupffer Cells of Nonalcoholic Steatohepatitis Rats. (26504479)
2015
2
New insights into genes, immunity, and the occurrence of dermatophytosis. (25666672)
2015
3
Importance of determination of urine neutrophile gelatinase associated lipocalin in early detection of acute kidney injury. (24851612)
2014
4
Quantitative assessment of the effect of glutathione S-transferase genes GSTM1 and GSTT1 on hepatocellular carcinoma risk. (24399650)
2014
5
MICAL-family proteins: Complex regulators of the actin cytoskeleton. (23834433)
2014
6
Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection. (24270546)
2013
7
ZFX regulates glioma cell proliferation and survival in vitro and in vivo. (23322077)
2013
8
Extended spectrum beta lactamase peritonitis: Our experience. (24049286)
2013
9
Overexpression of RCAN1 isoform 4 in mouse neurons leads to a moderate behavioral impairment. (23317802)
2013
10
Three-dimensional conformal radiotherapy with concurrent chemotherapy for postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy and failure pattern. (24139225)
2013
11
In silico screening for palmitoyl substrates reveals a role for DHHC1/3/10 (zDHHC1/3/11)-mediated neurochondrin palmitoylation in its targeting to Rab5-positive endosomes. (23687301)
2013
12
Regulation of cathepsins S and L by cystatin F during maturation of dendritic cells. (22365146)
2012
13
A pilot study of laparoscopic gastric pull-up by using the natural orifice translumenal endoscopic surgery technique: a novel procedure for treating long-gap esophageal atresia (type a). (21859341)
2011
14
Animal models of retinal disease. (21377628)
2011
15
Constitutive activated Cdc42-associated kinase (Ack) phosphorylation at arrested endocytic clathrin-coated pits of cells that lack dynamin. (21169560)
2011
16
Human cell-death-inducing DFF45-like effector C induces apoptosis via caspase-8. (21865223)
2011
17
Trimethopim-sulfamethoxazole compared with benzathine penicillin for treatment of impetigo in Aboriginal children: a pilot randomised controlled trial. (20415992)
2010
18
Polymorphism of the ERalpha and CYP1B1 genes in endometrial cancer in a Polish subpopulation. (20492382)
2010
19
Elevated plasma adiponectin levels in patients with chronic obstructive pulmonary disease. (20819268)
2010
20
Genetic admixture of eight Mexican indigenous populations: based on five polymarker, HLA-DQA1, ABO, and RH loci. (18770527)
2008
21
HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivity. (18954467)
2008
22
IL-19 and IL-20: two novel cytokines with importance in inflammatory diseases. (17465720)
2007
23
Adipocytokines - novel link between inflammation and vascular function? (17229978)
2006
24
Regulatory framework for the treatment of orphan diseases (21290666)
2006
25
Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment. (16815318)
2006
26
Recent knowledge about intestinal absorption and cleavage of carotenoids]. (15771974)
2005
27
Validation of in vivo pharmacodynamic activity of a novel PDGF receptor tyrosine kinase inhibitor using immunohistochemistry and quantitative image analysis. (16093435)
2005
28
Circulating vascular endothelial growth factor in cutaneous malignant melanoma. (15840099)
2005
29
The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by L-DOPA. (15084427)
2004
30
Detection of autoantibody against carbonic anhydrase II in various liver diseases by enzyme-linked immunosorbent assay using appropriate conditions. (15026266)
2004
31
Immature intrinsic nerve innervations of pyloric muscle in idiopathic hypertrophic pyloric stenosis. (15318280)
2004
32
Diagnosis and management of Bell's palsy. (12602224)
2003
33
Overexpression, purification, and characterization of human and bovine mitochondrial ATPase inhibitors: comparison of the properties of mammalian and yeast ATPase inhibitors. (14740888)
2003
34
Figs--the earliest known ancient drug for cutaneous anthrax. (12549964)
2003
35
Further delineation of the congenital form of X-linked dyskeratosis congenita (Hoyeraal-Hreidarsson syndrome). (14648217)
2003
36
Beyond blood pressure: the endothelium and atherosclerosis progression. (12383592)
2002
37
Comparison of luteal phase profile in gonadotrophin stimulated cycles with or without a gonadotrophin-releasing hormone antagonist. (11679500)
2001
38
Role of phosphatidylinositol 3,4,5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase-1. (9895304)
1999
39
A phase II trial of docetaxel (Taxotere) in hormone-refractory prostate cancer: correlation of antitumor effect to phosphorylation of Bcl-2. (10604264)
1999
40
Current status on new anticoagulant and antithrombotic drugs and devices. (9262116)
1997
41
Effects of p53 mutations on apoptosis in mouse intestinal and human colonic adenomas. (9294187)
1997
42
Proteus syndrome: new findings in seven patients. (9050755)
1997
43
Relation between plasma PAI activity and adipsin levels. (8560438)
1995
44
Polymorphisms in the alanine:glyoxylate aminotransferase gene and their application to the prenatal diagnosis of primary hyperoxaluria type 1. (8592623)
1995
45
Phosphotyrosine phosphatase activity of human periodontal ligament fibroblasts (HPLF)]. (2134890)
1990
46
Human glucosamine-6-sulfatase cDNA reveals homology with steroid sulfatase. (3196333)
1988
47
The pathology of urethral stricture. (781310)
1976
48
The pathogenesis and management of status asthmaticus. (5525203)
1970
49
Adult Fanconi syndrome and multiple myelomatosis. (5798628)
1969
50

Variations for Epidermolysis Bullosa Simplex

About this section

Expression for genes affiliated with Epidermolysis Bullosa Simplex

About this section
Search GEO for disease gene expression data for Epidermolysis Bullosa Simplex.

Pathways for genes affiliated with Epidermolysis Bullosa Simplex

About this section

GO Terms for genes affiliated with Epidermolysis Bullosa Simplex

About this section

Cellular components related to Epidermolysis Bullosa Simplex according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1intermediate filament cytoskeletonGO:00451119.9DST, PLEC
2keratin filamentGO:00450959.7KRT1, KRT14, KRT5
3hemidesmosomeGO:00300569.4COL17A1, ITGB4, PLEC
4intermediate filamentGO:00058829.1BFSP2, KRT10

Biological processes related to Epidermolysis Bullosa Simplex according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1response to woundingGO:00096119.6DST, ITGB4
2hemidesmosome assemblyGO:00315819.4COL17A1, ITGB4, KRT14, KRT5
3epidermis developmentGO:00085448.9COL17A1, KRT17, TGM5

Sources for Epidermolysis Bullosa Simplex

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet